Jinan, China

Yanling Cheng

This inventor holds 1 USPTO granted patent. Top assignees: Shandong Academy of Pharmaceutical Sciences, Shandong Freda Pharmaceutical Group Co., Ltd.. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yanling Cheng: Innovator in Joint Cavity Injection Preparations

Introduction

Yanling Cheng is a prominent inventor based in Jinan, China. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of joint cavity injection preparations. Her innovative work focuses on enhancing the biocompatibility and safety of these preparations.

Latest Patents

Yanling Cheng holds a patent for a joint cavity injection preparation that utilizes deacetylated xanthan gum (XG) as its active ingredient. This preparation is notable for its molecular weight range of 500,000 to 20,000,000. The joint cavity injection preparation she developed offers higher biocompatibility and a safer wide-dosage range compared to existing alternatives.

Career Highlights

Throughout her career, Yanling Cheng has worked with notable organizations such as Shandong Freda Pharmaceutical Group Co., Ltd. and Shandong Academy of Pharmaceutical Sciences. Her experience in these institutions has allowed her to advance her research and contribute to the pharmaceutical industry.

Collaborations

Yanling Cheng has collaborated with esteemed colleagues, including Daizhou Zhang and Lei Chen. These partnerships have further enriched her research and development efforts in the field of joint cavity injections.

Conclusion

Yanling Cheng's innovative work in joint cavity injection preparations exemplifies her commitment to improving pharmaceutical solutions. Her contributions are paving the way for safer and more effective treatments in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…